Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ekso Bionics (NASDAQ:EKSO – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Ekso Bionics Trading Down 5.6 % NASDAQ:EKSO opened at $1.17 on Tuesday. The company has a quick ratio of 2.15, a current ratio of 2.85 […]

Leave a Reply

Your email address will not be published.

Previous post Frontline (NYSE:FRO) Price Target Raised to $21.10
Next post Ravens RT Morgan Moses doubtful to face Seahawks because of shoulder injury